The
Promise of
Interleukin-2
Therapy

4 - 7 Sept. 2024

for autoimmune and inflammatory diseases, allergy, transplantation and cancer

Auditorium
Centre international de Conférences Sorbonne Université

4 place Jussieu, Patio

75005 - Paris, France

Abstract submission*

*To submit before June 15th, 2024 to il2.congress.2024@gmail.com

2024 Agenda

click here for the detailed programme

General

Wed. 4th

Thu. 5th

Fri. 6th

Sat. 7th

Wed. 4

Thu. 5

Fri. 6

Sat. 7

6.00 pm

9.00 am

8.00 pm

Opening Session

Keynote Lectures

Session I - On mechanistic aspects

Welcome Reception

10.30 am

Coffee Break

11.00 am

Session II - Lessons from current clinical trials with native IL-2

1.00 pm

Lunch & Posters

2.00 pm

Session III - On mechanistic aspects

3.30 pm

Coffee Break

4.30 pm

Session IV – Treg and IL2 in brain disorders

Session V – immunotherapy of brain disorders

11.00 am

Coffee Break

1.00 pm

Lunch & Posters

2.00 pm

Session VII - IL-2 and Treg cell therapies (2)

4.00 pm

Session VIII - Novel IL-2s, vectorisation and combination therapies

6.00 pm

Drinks & Posters

4.00 pm

Coffee Break

Session IX - IL-2 in cancer therapy

11.00 am

Coffee Break

11.30 am

Session X – IL-2: the pharma perspective

1.30 pm

END OF THE MEETING

6.30 pm

7.00 pm

End of day

11.30 am

Session VI – IL-2 and Treg cells therapies (1)

Schedule

Confirmed Speakers

(by alphabetical order)

Christoph Binder, Pierre Ellul, Ron Germain, Jonathan Kipnis, David Klatzmann, Zhanguo Li, Adrian Liston, Ziad Mallat, Diane Mathis, Thomas Malek, Alexander Marson, Marc Martinez Llordella, Suman Mitra, Janie Robert, Aleksander Rudensky, Jamie Spangler, Shimon Sakaguchi, Qizhi Tang, Lucy Walker, Benjamin Youngblood, Jonathan Zalevsky

Confirmed Speakers